Kipp Weiskopf

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

Stephen B. Willingham, Jens-Peter Volkmer, Andrew J. Gentles et al. · Proceedings of the National Academy of Sciences · 2012 · 1.7K citations · Full text

Medicine, Immunology, Oncology +17

Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47

Mark P. Chao, Siddhartha Jaiswal, Rachel Weissman-Tsukamoto et al. · Science Translational Medicine · 2010 · 760 citations

Life Sciences, Immunology, Oncology +11

Anti-CD47 antibody–mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response

Diane Tseng, Jens-Peter Volkmer, Stephen B. Willingham et al. · Proceedings of the National Academy of Sciences · 2013 · 649 citations · Full text

Life Sciences, Immunology, Oncology +17

Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy

Amira Barkal, Kipp Weiskopf, Kevin S. Kao et al. · Nature Immunology · 2017 · 558 citations · Full text

Life Sciences, Immunology, Oncology +16

Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies

Kipp Weiskopf, Aaron M. Ring, Chia Chi M. Ho et al. · Science · 2013 · 494 citations · Full text

Life Sciences, Immunology, Oncology +17